A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

Completed · Phase 3

Conditions studied: Thermal Burns

In brief

This study will be a three-arms study intending to demonstrate superiority of NexoBrid treatment over the Gel Vehicle placebo control treatment and over SOC in thermal burn subjects. The study objectives are: 1. To demonstrate the efficacy of enzymatic eschar removal with NexoBrid by providing complete eschar removal as compared with Gel vehicle, 2. To demonstrate the efficacy of enzymatic eschar removal with NexoBrid by providing earlier complete eschar removal, reduction in patients' surgical burden and its related blood loss as compared to SOC, 3. To assess the safety of NexoBrid compared to SOC, including demonstration that treatment with NexoBrid does not cause an unacceptable level of harm on wound closure outcome and long term outcomes of cosmesis and function.

Key facts

Study ID
NCT02148705
Run by
MediWound Ltd
People needed
175
Starts
2015-05-27
Expected to finish
2020-08-20
Last updated by the study team
2024-07-10

Who can join

Age: 18 and older, up to 77. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.